Company: NTWK
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001493152-25-015950
Chunk: 84

Company: NETSOL TECHNOLOGIES INC
Filing Date: 2025-09-29
Form: 10-K
Item: Item 8
Chunk 84
---
 liability associated with the unremitted earnings attributable to the foreign subsidiaries.

NOTE
14 - STOCKHOLDERS’ EQUITY

During
the years ended June 30, 2025 and 2024, the Company issued 58,335
and 70,035
shares of common stock, respectively, to the independent Board
of Directors as part of their board compensation. The grant date fair value of the shares was $159,000
for each period, and was recorded as compensation expense in the accompanying
consolidated financial statements.

During
the year ended June 30, 2025, the Company issued 59,528 shares of common stock to the CEO for his bonus earned in fiscal year 2024. The
fair market value of the shares was $151,201.

During
the year ended June 30, 2025, the Company issued 2,680
shares of common stock to a consultant pursuant to the terms of his consultancy agreement. The grant date fair value of the shares
was $8,333
and was recorded as compensation expense in the accompanying consolidated financial statements.

During
the year ended June 30, 2024, the Company issued 5,000
shares of common stock to employees pursuant to the terms of their employment agreements. The grant date fair value of the shares
was $9,050
and was recorded as compensation expense in the accompanying consolidated financial statements.

NOTE
15 – EQUITY INCENTIVE PLAN

At
the Company’s 2025 annual meeting of shareholders, the shareholders approved the 2025 Equity Incentive Plan (the “2025 Plan”).
The 2025 Plan is the Company’s sole active equity compensation plan and provides for the grant of stock options, stock appreciation
rights, restricted stock, restricted stock units, performance awards, and other stock-based awards to employees, directors, and consultants.
The maximum number of shares of common stock authorized for issuance under the 2025 Plan is 1,100,000. Shares subject to awards that
are forfeited, canceled, or expire without being exercised become available for grant under the plan. The 2025 Plan is administered by
the Compensation Committee of the Board of Directors, which has discretion to determine the terms of awards, including vesting and performance
conditions. The exercise price of stock options may not be less than the fair market value of the Company’s common stock on the
date of grant, and the maximum term of any option is